The conjugative metabolism of 4-methylumbelliferone and deconjugation to the parent drug examined by isolated perfused liver and in vitro liver homogenate of rats
- PMID: 2743496
- DOI: 10.1248/cpb.37.475
The conjugative metabolism of 4-methylumbelliferone and deconjugation to the parent drug examined by isolated perfused liver and in vitro liver homogenate of rats
Abstract
We examined the disposition of 4-methylumbelliferone (4-MU) and its conjugative metabolites, glucuronide (4-MUG) and sulfate (4-MUS), using a single-pass rat liver perfusion system. When 4-MU was delivered, the steady-state hepatic extraction ratio for 4-MU was very high (approximately 1.0) and its conjugative metabolites, 4-MUG and 4-MUS, appeared to a large extent in the effluent perfusate. The biliary excretion rate of the 4-MUG conjugated from 4-MU was 44% of the infusion rate at the steady-state, whereas those of 4-MU and 4-MUS were less than 1% of the infusion rate. When 4-MUG was delivered, the steady-state hepatic extraction ratio for 4-MUG was very low (less than 0.05) and the removal rate of 4-MUG from the perfusate was almost identical to the excretion rate of 4-MUG into the bile, while 4-MU and 4-MUS were slightly excreted into the bile (1% of the total biliary excretion rate), suggesting that a little deconjugation of 4-MUG to 4-MU occurred in the liver. Similarly, 4-MU and 4-MUS were not detectable in the effluent perfusate. The apparent extraction ratio (Eapp) for the intracellularly conjugated 4-MUG was approximately twenty times higher than that for the pre-conjugated 4-MUG. This discrepancy between the values of Eapp for the intracellularly conjugated and pre-conjugated 4-MUG might be attributed mainly to the diffusional barrier for the metabolite between the blood and hepatocytes, as suggested in the previous simulation (J. Pharmacokin, Biopharm., 15, 399 (1987].(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Membrane-limited hepatic transport of the conjugative metabolites of 4-methylumbelliferone in rats.J Pharm Sci. 1988 Aug;77(8):688-92. doi: 10.1002/jps.2600770809. J Pharm Sci. 1988. PMID: 3210158
-
Futile cycling between 4-methylumbelliferone and its conjugates in perfused rat liver.Hepatology. 1993 May;17(5):838-53. Hepatology. 1993. PMID: 8491453
-
Kinetics of hepatic transport of 4-methylumbelliferone in rats. Analysis by multiple indicator dilution method.J Pharmacokinet Biopharm. 1987 Feb;15(1):25-38. doi: 10.1007/BF01062937. J Pharmacokinet Biopharm. 1987. PMID: 3305862
-
Pharmacokinetic study of 4-methylumbelliferone in rats: influence of dose on its first-pass hepatic elimination.J Pharmacobiodyn. 1986 Feb;9(2):117-24. doi: 10.1248/bpb1978.9.117. J Pharmacobiodyn. 1986. PMID: 3712212
-
Corticosteroid metabolism in isolated perfused rat liver and kidney. Experimental studies with emphasis on aldosterone.Acta Physiol Scand Suppl. 1995;627:1-42. Acta Physiol Scand Suppl. 1995. PMID: 8848946 Review.
Cited by
-
The in vitro metabolism of irinotecan (CPT-11) by carboxylesterase and beta-glucuronidase in human colorectal tumours.Br J Clin Pharmacol. 2006 Jul;62(1):122-9. doi: 10.1111/j.1365-2125.2005.02477.x. Br J Clin Pharmacol. 2006. PMID: 16842384 Free PMC article.
-
Hepatic conjugation/deconjugation cycling pathways. Computer simulations examining the effect of Michaelis-Menten parameters, enzyme distribution patterns, and a diffusional barrier on metabolite disposition.J Pharmacokinet Biopharm. 1996 Apr;24(2):219-43. doi: 10.1007/BF02353490. J Pharmacokinet Biopharm. 1996. PMID: 8875348
-
Stereoselective hepatic disposition of model diastereomeric acyl glucuronides.J Pharmacokinet Pharmacodyn. 2004 Feb;31(1):1-27. doi: 10.1023/b:jopa.0000029486.60317.25. J Pharmacokinet Pharmacodyn. 2004. PMID: 15346849
MeSH terms
Substances
LinkOut - more resources
Research Materials